Table 1.
Sample descriptive.
| n | Sex | Age | Handedness | Medication | IQ* | PANSSc | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| w | m | Mean (sd) | Range | Right | Left | CPZean (mean) | ADbn | Positive mean | Negative mean | General mean | |||
| HC | 45 | 19 | 26 | 20.7 (5.3) | 13–35 | 39 | 6 | 0 | 0 | 109.1 | – | – | – |
| Bip | 25 | 10 | 15 | 23.5 (6.3) | 14–35 | 23 | 2 | 2 (122.3) | 9 | 109.4 | 8.8 | 11.7 | 26.5 |
| HR | 59 | 25 | 34 | 23.4 (5.2) | 14–34 | 53 | 6 | 10 (115.0) | 18 | 103.7 | 9.9 | 12.0 | 27.6 |
| UHR | 73 | 28 | 45 | 18.7 (4.8) | 13–35 | 62 | 11 | 19 (184.6) | 14 | 101.9 | 14.8 | 15.9 | 34.3 |
*
IQ was estimated from MWT-B for subjects >18 years and from LPS and HAWIK for subjects <18 years.
a
Chlorpromazine equivalent.
b
Antidepressants: HC, healthy controls; Bip, at-risk-bipolar; HR, high-risk; UHR, ultra-high-risk.
c
Positive and negative symptom scale.